ArticleBreast cancer research and treatment2016

Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.

Akira I Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.